• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体内注射地塞米松治疗迟发性滤过泡相关眼内炎

Intravitreal dexamethasone in the management of delayed-onset bleb-associated endophthalmitis.

作者信息

Jacobs David J, Pathengay Avinash, Flynn Harry W, Leng Theodore, Miller Darlene, Shi Wei

机构信息

Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.

出版信息

Int J Inflam. 2012;2012:503912. doi: 10.1155/2012/503912. Epub 2012 Jan 11.

DOI:10.1155/2012/503912
PMID:22288020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3263617/
Abstract

Purpose. To report the visual acuity (VA) outcomes and culture results of delayed-onset bleb-associated endophthalmitis (BAE) with and without intravitreal dexamethasone (IVD). Methods. Retrospective nonrandomized comparative case series of BAE at Bascom Palmer Eye Institute between January 1, 1996 and December 31, 2009. Clinical data were compared using the 2-sided Student's t-test for patients who received IVD and patients who did not receive IVD. Results. 70/83 (84%) received IVD, and 13/83 (16%) did not receive IVD. Mean baseline VA was 20/90 in the IVD group and 20/70 in the group that did not receive IVD (P = 0.57). Mean presenting VA was 0.9/200 in the IVD group and 1.7/200 in the group that did not receive IVD (P = 0.23). Repeat cultures were positive in 2/70 (3%) IVD cases and 1/13 (8%) cases that did not receive IVD (P = 0.57). Mean VA at 1 month was 5/200 in the IVD group and 1.8/200 in the group that did not receive IVD, logMARΔ of 0.85 and 1.56, respectively (P = 0.02). Mean VA at 3 months was 7/200 in the IVD group and 3/200 in the group that did not receive IVD, logMARΔ of 0.74 and 1.33, respectively (P = 0.14). Conclusion. In the current study of BAE, IVD was associated with improved short-term VA outcomes without an increased rate of persistent infection.

摘要

目的。报告有和没有玻璃体内注射地塞米松(IVD)的迟发性滤过泡相关眼内炎(BAE)的视力(VA)结果和培养结果。方法。对1996年1月1日至2009年12月31日在巴斯科姆·帕尔默眼科研究所的BAE进行回顾性非随机对照病例系列研究。使用双侧学生t检验对接受IVD和未接受IVD的患者的临床数据进行比较。结果。83例中有70例(84%)接受了IVD,13例(16%)未接受IVD。IVD组的平均基线视力为20/90,未接受IVD组为20/70(P = 0.57)。IVD组的平均就诊时视力为0.9/200,未接受IVD组为1.7/200(P = 0.23)。重复培养在2/70例(3%)接受IVD的病例和1/13例(8%)未接受IVD的病例中呈阳性(P = 0.57)。IVD组1个月时的平均视力为5/200,未接受IVD组为1.8/200,对数最小分辨角变化(logMARΔ)分别为0.85和1.56(P = 0.02)。IVD组3个月时的平均视力为7/200,未接受IVD组为3/200,logMARΔ分别为0.74和1.33(P = 0.14)。结论。在当前关于BAE的研究中,IVD与短期视力结果改善相关,且持续性感染率未增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a12/3263617/130c5c36d8b6/IJI2012-503912.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a12/3263617/130c5c36d8b6/IJI2012-503912.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a12/3263617/130c5c36d8b6/IJI2012-503912.001.jpg

相似文献

1
Intravitreal dexamethasone in the management of delayed-onset bleb-associated endophthalmitis.玻璃体内注射地塞米松治疗迟发性滤过泡相关眼内炎
Int J Inflam. 2012;2012:503912. doi: 10.1155/2012/503912. Epub 2012 Jan 11.
2
Delayed-onset bleb-associated endophthalmitis: presentation and outcome by culture result.迟发性水泡相关性眼内炎:根据培养结果的表现及预后
Clin Ophthalmol. 2011;5:739-44. doi: 10.2147/OPTH.S17975. Epub 2011 Jun 2.
3
Adjunctive intravitreal dexamethasone in the treatment of acute endophthalmitis following cataract surgery.辅助性玻璃体内注射地塞米松治疗白内障术后急性眼内炎
Clin Ophthalmol. 2008 Mar;2(1):139-45. doi: 10.2147/opth.s2128.
4
Bleb-associated endophthalmitis: clinical characteristics and visual outcomes.泡性相关眼内炎:临床特征与视力预后
Ophthalmology. 2004 Aug;111(8):1495-503; discussion 1503. doi: 10.1016/j.ophtha.2004.01.028.
5
Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes.迟发性水泡相关性眼内炎:临床特征及视力预后
Ophthalmology. 2002 May;109(5):985-91. doi: 10.1016/s0161-6420(02)00965-x.
6
Endophthalmitis caused by Streptococcus pneumoniae.肺炎链球菌引起的眼内炎。
Am J Ophthalmol. 2004 Aug;138(2):231-6. doi: 10.1016/j.ajo.2004.03.008.
7
Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema.玻璃体内注射地塞米松植入术治疗对玻璃体内注射贝伐单抗耐药的人工晶状体眼黄斑囊样水肿
Korean J Ophthalmol. 2019 Jun;33(3):259-266. doi: 10.3341/kjo.2018.0106.
8
Endophthalmitis caused by Bacillus species.芽孢杆菌属引起的眼内炎。
Am J Ophthalmol. 2008 May;145(5):883-8. doi: 10.1016/j.ajo.2007.12.026. Epub 2008 Mar 4.
9
Open globe injuries with positive intraocular cultures: factors influencing final visual acuity outcomes.眼内培养阳性的开放性眼球损伤:影响最终视力结果的因素
Ophthalmology. 2003 Aug;110(8):1560-6. doi: 10.1016/S0161-6420(03)00497-4.
10
Bleb-associated endophthalmitis: Proportion, presentation, management and outcomes in Victoria, Australia.眼内泡相关性眼内炎:在澳大利亚维多利亚州的比例、表现、处理和结果。
Clin Exp Ophthalmol. 2019 Jul;47(5):588-597. doi: 10.1111/ceo.13477. Epub 2019 Mar 12.

引用本文的文献

1
Visual outcomes of acute bacterial endophthalmitis treated with adjuvant intravitreal dexamethasone: A meta-analysis and systematic review.辅助玻璃体内注射地塞米松治疗急性细菌性眼内炎的疗效观察:Meta 分析和系统评价。
Indian J Ophthalmol. 2022 Aug;70(8):2835-2841. doi: 10.4103/ijo.IJO_955_21.
2
Intraocular Foreign Bodies: Clinical Characteristics and Prognostic Factors Influencing Visual Outcome and Globe Survival in 373 Eyes.眼内异物:373 只眼的临床特征及影响视力预后和眼球存活的预后因素
J Ophthalmol. 2019 Feb 13;2019:5208092. doi: 10.1155/2019/5208092. eCollection 2019.
3
Evidence for and against intravitreous corticosteroids in addition to intravitreous antibiotics for acute endophthalmitis.

本文引用的文献

1
Delayed-onset bleb-associated endophthalmitis: presentation and outcome by culture result.迟发性水泡相关性眼内炎:根据培养结果的表现及预后
Clin Ophthalmol. 2011;5:739-44. doi: 10.2147/OPTH.S17975. Epub 2011 Jun 2.
2
Delayed-onset bleb-associated endophthalmitis (1996-2008): causative organisms and visual acuity outcomes.迟发型滤泡相关性眼内炎(1996-2008 年):致病病原体和视力预后。
Retina. 2011 Feb;31(2):344-52. doi: 10.1097/IAE.0b013e3181e09810.
3
Adjunctive intravitreal dexamethasone in the treatment of acute endophthalmitis following cataract surgery.
除玻璃体内注射抗生素外,玻璃体内注射皮质类固醇用于急性眼内炎的支持和反对证据。
Int Ophthalmol Clin. 2014 Spring;54(2):215-24. doi: 10.1097/IIO.0000000000000020.
4
Risk factors for endophthalmitis and retinal detachment with retained intraocular foreign bodies.眼内异物残留所致眼内炎和视网膜脱离的危险因素。
J Ophthalmol. 2012;2012:758526. doi: 10.1155/2012/758526. Epub 2012 Apr 26.
辅助性玻璃体内注射地塞米松治疗白内障术后急性眼内炎
Clin Ophthalmol. 2008 Mar;2(1):139-45. doi: 10.2147/opth.s2128.
4
Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial.玻璃体内注射地塞米松作为术后眼内炎治疗的辅助手段:一项前瞻性随机试验。
Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1200-5. doi: 10.1007/s00417-005-0133-1. Epub 2005 Oct 19.
5
Bleb-associated endophthalmitis: clinical characteristics and visual outcomes.泡性相关眼内炎:临床特征与视力预后
Ophthalmology. 2004 Aug;111(8):1495-503; discussion 1503. doi: 10.1016/j.ophtha.2004.01.028.
6
Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis.玻璃体内注射类固醇治疗术后眼内炎后的视力预后。
Ophthalmology. 2000 Mar;107(3):486-9. doi: 10.1016/s0161-6420(99)00139-6.
7
Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study.玻璃体内注射地塞米松治疗外源性细菌性眼内炎:一项前瞻性随机研究的结果
Br J Ophthalmol. 1999 Sep;83(9):1050-5. doi: 10.1136/bjo.83.9.1050.
8
Additional procedures after the initial vitrectomy or tap-biopsy in the Endophthalmitis Vitrectomy Study.眼内炎玻璃体切除研究中初次玻璃体切除或穿刺活检后的附加手术。
Ophthalmology. 1998 Apr;105(4):707-16. doi: 10.1016/s0161-6420(98)94028-3.
9
Delayed-onset endophthalmitis associated with conjunctival filtering blebs.与结膜滤过泡相关的迟发性眼内炎。
Ophthalmology. 1997 May;104(5):746-52. doi: 10.1016/s0161-6420(97)30238-3.
10
Persistent endophthalmitis after intravitreal antimicrobial therapy.玻璃体内抗菌治疗后持续性眼内炎
Ophthalmology. 1995 Mar;102(3):382-7. doi: 10.1016/s0161-6420(95)31011-1.